Literature DB >> 9014791

Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?

M Komajda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9014791      PMCID： PMC484594          DOI： 10.1136/hrt.76.6.465

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 3.  Molecular basis of familial cardiomyopathies.

Authors:  K Schwartz; L Carrier; P Guicheney; M Komajda
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

4.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

5.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.

Authors:  H L Sweeney; A J Straceski; L A Leinwand; B A Tikunov; L Faust
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

6.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

7.  Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.

Authors:  C A MacRae; N Ghaisas; S Kass; S Donnelly; C T Basson; H C Watkins; R Anan; L H Thierfelder; K McGarry; E Rowland
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  M Lechin; M A Quiñones; A Omran; R Hill; Q T Yu; H Rakowski; D Wigle; C C Liew; M Sole; R Roberts
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

9.  Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy.

Authors:  G Bonne; L Carrier; J Bercovici; C Cruaud; P Richard; B Hainque; M Gautel; S Labeit; M James; J Beckmann; J Weissenbach; H P Vosberg; M Fiszman; M Komajda; K Schwartz
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330
  9 in total
  1 in total

Review 1.  Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.

Authors:  Haige Ye; Aakash Desai; Shengjian Huang; Dayoung Jung; Richard Champlin; Dongfeng Zeng; Fangfang Yan; Krystle Nomie; Jorge Romaguera; Makhdum Ahmed; Michael L Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.